ArticleHealth care analysis : HCA : journal of health philosophy and policy2026
Access to Cancer Medicines in Türkiye Through Legal Avenues: An Analysis from the Perspective of Medical Ethics.
Article in Health care analysis : HCA : journal of health philosophy and policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer remains a leading cause of disease-related mortality worldwide. Advances in oncology have enabled the development of novel therapies, including targeted therapies and immunotherapies, that act more selectively on cancer cells than conventional treatments. In Türkiye, medicine reimbursement is administered by the Social Security Institution (SSI) through the national health insurance system. However, some newly developed and high-cost cancer medicines are not reimbursed, leading some patients to seek public coverage through litigation. This practice raises ethical concerns by creating tension between individual claims to the right to health and the fair allocation of scarce resources, while also drawing attention to inequities in access to healthcare. This article analyzes litigation-based access to cancer medicines in Türkiye through the four principles of biomedical ethics and discusses key ethical challenges, with a focus on fair, transparent, and sustainable reimbursement processes.
Indexed as
Identifiers
42313247What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.